Austin Duke, PhD
Venture Investing Director
Austin Duke currently serves as Venture Investing Director at UnityPoint Health Ventures where he helps lead all investment activities including sourcing, diligence, execution and post-investment support. Austin brings more than 10 years of biomedical research and development experience along with a deep understanding of the opportunities and challenges presented to startup companies.
Prior to joining UnityPoint Health, Austin served as Chief Science Officer at Nexeon MedSystems Inc, where he led scientific, clinical and regulatory activities in support of the development and commercialization of Nexeon’s neurostimulation technology platform. Prior to Nexeon, Austin served as Vice President of Emerging Therapies at Rosellini Scientific and co-founded Nuviant Medical. Austin obtained his PhD in Biomedical Engineering from Vanderbilt University and his B.S. in Biomedical Engineering from North Carolina State University.